FTC order stops the marketer of "Thrive" supplement from making baseless claims
Last updated 7/16/2020 at 3:06am
WASHINGTON – The California-based marketer of a supplement called Thrive, which consists mainly of vitamin C and herbal extracts, is barred from continuing to make baseless claims that it can treat, prevent or reduce the risk of COVID-19, under an administrative settlement with the Federal Trade Commission announced Friday, July 10.
The FTC proposed order also bars the marketer of Thrive, Marc Ching, from making similarly unsupported cancer treatment or prevention claims for products containing CBD. The case against Ching is the FTC’s first against a marketer of a supposed COVID-19-rel...